<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Kromek Group Plc — News on 6ix</title>
<link>https://6ix.com/company/kromek-group-plc</link>
<description>Latest news and press releases for Kromek Group Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 09 Mar 2026 13:36:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/kromek-group-plc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835e7db78dffbe2df1292c5.webp</url>
<title>Kromek Group Plc</title>
<link>https://6ix.com/company/kromek-group-plc</link>
</image>
<item>
<title>Director Share Purchase</title>
<link>https://6ix.com/company/kromek-group-plc/news/director-share-purchase-19</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/director-share-purchase-19</guid>
<pubDate>Mon, 09 Mar 2026 13:36:00 GMT</pubDate>
<description>Kromek Group PLC announced that its Non-executive Chairman, Rakesh Sharma, purchased 102,669 ordinary shares at 9.74p per share on March 9, 2026. This transaction increases his total holding to 1,310,208 ordinary shares, representing 0.2% of the company's issued share capital. This director's share purchase indicates confidence in the company's future prospects.
Disclaimer*</description>
</item>
<item>
<title>Interim Results</title>
<link>https://6ix.com/company/kromek-group-plc/news/interim-results-308</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/interim-results-308</guid>
<pubDate>Tue, 20 Jan 2026 07:00:00 GMT</pubDate>
<description>Kromek Group PLC reported a significant increase in revenue to £15.0 million for the six months ended 31 October 2025, up from £3.7 million in the prior year, driven by substantial growth in both Advanced Imaging and CBRN Detection segments. The company achieved a gross margin of 71.7% and an adjusted EBITDA of £6.0 million, a notable improvement from a £2.3 million loss previously. Profit before tax stood at £3.1 million, contrasting with a £5.7 million loss in the prior period. Cash and cash e</description>
</item>
<item>
<title>Notice of Results</title>
<link>https://6ix.com/company/kromek-group-plc/news/notice-of-results-199</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/notice-of-results-199</guid>
<pubDate>Tue, 16 Dec 2025 07:00:00 GMT</pubDate>
<description>Kromek Group PLC has announced that it will release its interim results for the six months ending 31 October 2025 on Tuesday, 20 January 2026. The company will host an online question and answer session for investors on Monday, 26 January 2026, at 4:00 PM GMT, with a recording of the results presentation to be available by midday on Friday, 23 January 2026.
Disclaimer*</description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/kromek-group-plc/news/holdings-in-company-644</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/holdings-in-company-644</guid>
<pubDate>Mon, 15 Dec 2025 12:27:00 GMT</pubDate>
<description>David and Monique Newlands have notified Kromek Group PLC of a change in their major shareholding, resulting in a total of 4.838% of voting rights, comprising 4.502% in shares and 0.336% through financial instruments, specifically a spread bet. This change occurred on December 15, 2025, with their previous holding at 5.163%. The total number of voting rights held is 31,690,000.
Disclaimer*</description>
</item>
<item>
<title>Grant of Options, PDMR Dealings and TVR</title>
<link>https://6ix.com/company/kromek-group-plc/news/grant-of-options-pdmr-dealings-and-tvr</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/grant-of-options-pdmr-dealings-and-tvr</guid>
<pubDate>Tue, 28 Oct 2025 07:00:00 GMT</pubDate>
<description>Kromek Group PLC announced on October 28, 2025, the grant of options to directors and the exercise of options by the CEO. Options were granted to directors in lieu of cash payments, with exercise prices of 1p and 5.6p. CEO Arnab Basu exercised options over 110,000 Ordinary Shares at 1p each. Following this exercise, Basu holds options over 9,287,308 Ordinary Shares and has an interest in 3,198,750 Ordinary Shares. A total of 41,247,868 Ordinary Shares are under option. Lawrence Kinet and Jerel W</description>
</item>
<item>
<title>Result of AGM</title>
<link>https://6ix.com/company/kromek-group-plc/news/result-of-agm-588</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/result-of-agm-588</guid>
<pubDate>Mon, 27 Oct 2025 14:16:00 GMT</pubDate>
<description>Kromek Group PLC announced the results of its Annual General Meeting, where all resolutions were duly passed. For resolution 1, votes for totaled 238,908,491, representing 95.51% of votes cast, while votes against amounted to 11,243,902, or 4.49%. Resolution 2 saw 247,173,824 votes for (99.72%) and 700,461 votes against (0.28%). Resolution 3 had 215,613,296 votes for (99.72%) and 612,480 votes against (0.28%). Resolution 4 received 237,319,661 votes for (99.63%) and 872,818 votes against (0.37%)</description>
</item>
<item>
<title>Pre-close Trading Statement</title>
<link>https://6ix.com/company/kromek-group-plc/news/pre-close-trading-statement-9</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/pre-close-trading-statement-9</guid>
<pubDate>Mon, 27 Oct 2025 07:00:00 GMT</pubDate>
<description>Kromek Group expects to report revenue for H1 2026 of at least £14.5m, a significant increase from the £3.7m reported in H1 2025. This includes at least £8.2m in revenue from the Siemens Healthineers enablement agreement, compared to £nil in H1 2024. Underlying revenue is expected to be at least £6.3m, representing a 70% increase from the £3.7m in H1 2025, driven by growth in the CBRN Detection division and increased underlying revenue in Advanced Imaging. The company anticipates reporting profi</description>
</item>
<item>
<title>Notice of AGM and Publication of Annual Report</title>
<link>https://6ix.com/company/kromek-group-plc/news/notice-of-agm-and-publication-of-annual-report-5</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/notice-of-agm-and-publication-of-annual-report-5</guid>
<pubDate>Fri, 03 Oct 2025 09:06:00 GMT</pubDate>
<description>Kromek Group PLC announced the upcoming Annual General Meeting (AGM) to be held on Monday 27 October 2025, and the publication of its annual report for the year ended 30 April 2025. Lawrence Kinet and Jerel Whittingham will retire from the Board at the AGM's conclusion, having served as Non-executive Directors since 2013. Matthew Boyle has been appointed as a Non-executive Director, effective from the AGM's conclusion, and will also chair the Remuneration Committee. Boyle previously sold his com</description>
</item>
<item>
<title>Final Results</title>
<link>https://6ix.com/company/kromek-group-plc/news/final-results-344</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/final-results-344</guid>
<pubDate>Tue, 16 Sep 2025 06:00:00 GMT</pubDate>
<description>Kromek Group PLC reported its final results for the year ended April 30, 2025, with revenue increasing by 37% to £26.5m from £19.4m in 2024. Advanced Imaging revenue was £20.3m, up from £9.0m, while CBRN Detection revenue decreased to £6.2m from £10.4m. The gross margin improved significantly to 81% from 55%. Adjusted EBITDA increased to £10.3m compared to £3.1m in the prior year. Profit before tax was £3.1m, a substantial improvement from a £3.5m loss in 2024. The company repaid £5.5m term loan</description>
</item>
<item>
<title>New Biosecurity Award from UK MoD</title>
<link>https://6ix.com/company/kromek-group-plc/news/new-biosecurity-award-from-uk-mod</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/new-biosecurity-award-from-uk-mod</guid>
<pubDate>Mon, 11 Aug 2025 06:00:00 GMT</pubDate>
<description>New Biosecurity Award from UK MoD.</description>
</item>
<item>
<title>$5m received under Siemens Healthineers agreement</title>
<link>https://6ix.com/company/kromek-group-plc/news/dollar5m-received-under-siemens-healthineers-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/dollar5m-received-under-siemens-healthineers-agreement</guid>
<pubDate>Mon, 28 Jul 2025 06:00:00 GMT</pubDate>
<description>$5m received under Siemens Healthineers agreement.</description>
</item>
<item>
<title>£1.7m contract win under UK Government Framework</title>
<link>https://6ix.com/company/kromek-group-plc/news/pound17m-contract-win-under-uk-government-framework</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/pound17m-contract-win-under-uk-government-framework</guid>
<pubDate>Mon, 21 Jul 2025 06:00:00 GMT</pubDate>
<description>£1.7m contract win under UK Government Framework.</description>
</item>
<item>
<title>Capital Markets Day Presentation</title>
<link>https://6ix.com/company/kromek-group-plc/news/capital-markets-day-presentation</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/capital-markets-day-presentation</guid>
<pubDate>Mon, 23 Jun 2025 10:40:00 GMT</pubDate>
<description>Capital Markets Day Presentation.</description>
</item>
<item>
<title>Capital Markets Day</title>
<link>https://6ix.com/company/kromek-group-plc/news/capital-markets-day-25</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/capital-markets-day-25</guid>
<pubDate>Wed, 18 Jun 2025 06:00:00 GMT</pubDate>
<description>Capital Markets Day.</description>
</item>
<item>
<title>Issue of Equity and Total Voting Rights</title>
<link>https://6ix.com/company/kromek-group-plc/news/issue-of-equity-and-total-voting-rights-57</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/issue-of-equity-and-total-voting-rights-57</guid>
<pubDate>Mon, 09 Jun 2025 06:00:00 GMT</pubDate>
<description>Issue of Equity and Total Voting Rights.</description>
</item>
<item>
<title>New Nuclear Security Orders</title>
<link>https://6ix.com/company/kromek-group-plc/news/new-nuclear-security-orders</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/new-nuclear-security-orders</guid>
<pubDate>Wed, 28 May 2025 06:00:00 GMT</pubDate>
<description>New Nuclear Security Orders.</description>
</item>
<item>
<title>Directorate Change</title>
<link>https://6ix.com/company/kromek-group-plc/news/directorate-change-475</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/directorate-change-475</guid>
<pubDate>Thu, 08 May 2025 06:05:00 GMT</pubDate>
<description>Directorate Change.</description>
</item>
<item>
<title>Full Year 2025 Trading Update</title>
<link>https://6ix.com/company/kromek-group-plc/news/full-year-2025-trading-update-2</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/full-year-2025-trading-update-2</guid>
<pubDate>Thu, 08 May 2025 06:00:00 GMT</pubDate>
<description>Full Year 2025 Trading Update.</description>
</item>
<item>
<title>$25m received under Siemens Healthineers agreement</title>
<link>https://6ix.com/company/kromek-group-plc/news/dollar25m-received-under-siemens-healthineers-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/dollar25m-received-under-siemens-healthineers-agreement</guid>
<pubDate>Mon, 17 Feb 2025 07:00:00 GMT</pubDate>
<description>$25m received under Siemens Healthineers agreement.</description>
</item>
<item>
<title>Kromek Signs Agreements with Siemens Healthineers</title>
<link>https://6ix.com/company/kromek-group-plc/news/kromek-signs-agreements-with-siemens-healthineers</link>
<guid isPermaLink="true">https://6ix.com/company/kromek-group-plc/news/kromek-signs-agreements-with-siemens-healthineers</guid>
<pubDate>Thu, 30 Jan 2025 07:00:00 GMT</pubDate>
<description>Kromek Signs Agreements with Siemens Healthineers.</description>
</item>
</channel>
</rss>